Bethany Brookshire

Bethany Brookshire is a science journalist and author of Pests: How Humans Create Animal Villains, forthcoming from Ecco on December 6. Her work has appeared in Science News, Scientific American, The New York Times, The Washington Post, The Atlantic, Sierra, and other outlets. She is a host of the podcast Science for the People. Bethany holds a PhD in Physiology and Pharmacology from Wake Forest University School of Medicine.

Articles by Bethany Brookshire

Opinion: Are Cats Friends or Fiends?

Bethany Brookshire | | 4 min read

Book Excerpt from Pests

Bethany Brookshire | | 5 min read

Page 1 of 1 - 2 Total Items

Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.

June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.

Seeing and Sorting with Confidence

Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.

Streamlining Microbial Quality Control Testing

New innovations provide scientists with easy access to robust and accurate control samples for quality control applications.

Alamar Biosciences, Alzheimer's Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer's Disease

Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology.

How Alderley Analytical are Delivering eXtreme Robustness in Bioanalysis

Discover how Alderley Analytical meet regulatory demands and high-throughput challenges—processing 10,000+ dirty samples with consistent performance of the Xevo TQ Absolute XR Mass Spectrometer.